Literature DB >> 21046360

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.

Q Gong1, E W Gregg, J Wang, Y An, P Zhang, W Yang, H Li, H Li, Y Jiang, Y Shuai, B Zhang, J Zhang, R B Gerzoff, G Roglic, Y Hu, G Li, P H Bennett.   

Abstract

AIMS/HYPOTHESIS: We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period.
METHODS: In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group.
RESULTS: Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors. CONCLUSIONS/
INTERPRETATION: Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.

Entities:  

Mesh:

Year:  2010        PMID: 21046360     DOI: 10.1007/s00125-010-1948-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

Review 1.  Calculating the number needed to treat for trials where the outcome is time to an event.

Authors:  D G Altman; P K Andersen
Journal:  BMJ       Date:  1999-12-04

2.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

3.  Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.

Authors:  C L Kunzelman; W C Knowler; D J Pettitt; P H Bennett
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

Review 4.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

5.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

7.  Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes.

Authors:  Z S Chi; E T Lee; M Lu; H Keen; P H Bennett
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

8.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

Authors:  Kinori Kosaka; Mitsuihiko Noda; Takeshi Kuzuya
Journal:  Diabetes Res Clin Pract       Date:  2005-02       Impact factor: 5.602

9.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

10.  Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey.

Authors:  Edward W Gregg; Paul Sorlie; Ryne Paulose-Ram; Qiuping Gu; Mark S Eberhardt; Michael Wolz; Vicki Burt; Lester Curtin; Michael Engelgau; Linda Geiss
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

View more
  81 in total

Review 1.  The role of lifestyle change for prevention of cardiovascular disease in diabetes.

Authors:  Lisa R Staimez; Mary Beth Weber; Edward W Gregg
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

Review 2.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes.

Authors:  Matthew J O'Brien; Kai McKeever Bullard; Yan Zhang; Edward W Gregg; Mercedes R Carnethon; Namratha R Kandula; Ronald T Ackermann
Journal:  J Gen Intern Med       Date:  2018-04-12       Impact factor: 5.128

4.  The National Diabetes Prevention Programme: a pathway for prevention and wellbeing.

Authors:  Harpreet S Sood; Mahiben Maruthappu; Jonathan Valabhji
Journal:  Br J Gen Pract       Date:  2015-07       Impact factor: 5.386

Review 5.  Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers.

Authors:  Timothy J Lyons; Arpita Basu
Journal:  Transl Res       Date:  2012-01-31       Impact factor: 7.012

6.  Study protocol: Using peer support to aid in prevention and treatment in prediabetes (UPSTART).

Authors:  Michele Heisler; Jeffrey Kullgren; Caroline Richardson; Shelley Stoll; Cristina Alvarado Nieves; Deanne Wiley; Tali Sedgwick; Alyce Adams; Monique Hedderson; Eileen Kim; Megan Rao; Julie A Schmittdiel
Journal:  Contemp Clin Trials       Date:  2020-06-01       Impact factor: 2.226

Review 7.  Change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance.

Authors:  Maryna Popp Switzer; Sherif Elhanafi; Zinnia T San Juan
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

8.  Cost-effectiveness of a faith-based lifestyle intervention for diabetes prevention among African Americans: A within-trial analysis.

Authors:  Elizabeth C Rhodes; Eeshwar K Chandrasekar; Shivani A Patel; K M Venkat Narayan; Thomas V Joshua; Lovoria B Williams; Lucy Marion; Mohammed K Ali
Journal:  Diabetes Res Clin Pract       Date:  2018-09-28       Impact factor: 5.602

9.  Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.

Authors:  Ann L Albright; Edward W Gregg
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

10.  Authors' reply.

Authors:  Guangwei Li; Ping Zhang; Edward W Gregg; Michael M Engelgau; Peter H Bennett
Journal:  Lancet Diabetes Endocrinol       Date:  2014-07       Impact factor: 32.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.